Prevention Grants: Support efforts to prevent or delay the harms of ALS, emphasizing validation and translation over discovery. Read the RFA for Prevention Grants (pdf)
By invitation only, full proposal due: 5 p.m. EDT, July 19, 2023

Clinical Trial Awards: Support early to mid-phase (phase 1 or phase 2a) clinical trials of novel or repositioned therapeutics for ALS (either disease-modifying or symptomatic) Read the RFA for Clinical Trial Awards (pdf)
By invitation only, full proposal due: 5 p.m. EDT, Aug. 2, 2023